Schedule 13G ownership disclosure
Aptevo Therapeutics Inc.
Security class unavailable · CUSIP: 03835L108
Event date: 2019-03-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,273,862
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-19-000170
- Form type
- SC 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Mar 18, 2019
- Reporting period
- Mar 07, 2019
- Description
- Schedule 13G beneficial ownership